Health economic modelling to assess short-term costs of maternal overweight, gestational diabetes and related macrosomia – a pilot evaluation

Autor: Irene eLenoir-Wijnkoop, Eline M Van Der Beek, Johan eGarssen, Mark J C Nuijten, Ricardo eUauy

Publikováno v: Frontiers in Pharmacology, Vol 6 (2015)

Background: Despite the interest in the impact of overweight and obesity on public health, little is known about the social and economic impact of being born large for gestational age or macrosomic. Both conditions are related to maternal obesity and

Externí odkaz: https://doaj.org/article/ae8abdb47f9149319635483f550c6078

Nutrition economic evaluation of a probiotic in the prevention of antibiotic-associated diarrhea

Autor: Irene eLenoir-Wijnkoop, Mark J C Nuijten, Joyce eCraig, Christopher C Butler

Publikováno v: Frontiers in Pharmacology, Vol 5 (2014)

Introduction Antibiotic associated diarrhea (AAD) is common and frequently more severe in hospitalised elderly adults. It can lead to increased use of healthcare resources. We estimated the cost-effectiveness of a fermented milk with probiotic in pre

Externí odkaz: https://doaj.org/article/078d8187e2954e098779b6b29dd1fb68

Cost-utility analysis: Current methodological issues and future perspectives

Autor: Mark J C Nuijten, Dominique J Dubois

Publikováno v: Frontiers in Pharmacology, Vol 2 (2011)

The use of cost-effectiveness as final criterion in the reimbursement process for listing of new pharmaceuticals can be questioned from a scientific and policy point of view. There is a lack of consensus on main methodological issues and consequently

Externí odkaz: https://doaj.org/article/6f9d402421b6471ca817af2ea34e3a49

Cost-effectiveness in Clostridium difficile treatment decision-making

Autor: Mark J. C. Nuijten, Caroline E. Visser, Peter Speelman, Marja H. Pronk, Eric Claassen, W. Ken Redekop, Josbert J. Keller

Publikováno v: Nuijten, M J, Keller, J J, Visser, C E, Redekop, K, Claassen, E, Speelman, P & Pronk, M H 2015, ' Cost-effectiveness in Clostridium difficile treatment decision-making. ', World journal of clinical cases, vol. 3, no. 11, pp. 935-941 . https://doi.org/10.12998/wjcc.v3.i11.935
World journal of clinical cases, 3(11), 935-941. Baishideng Publishing Group

AIM: To develop a framework for the clinical and health economic assessment for management of Clostridium difficile infection (CDI). METHODS: CDI has vast economic consequences emphasizing the need for innovative and cost effective solutions, which w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5df8236ce83a4f0342c025c65a36a1d
https://hdl.handle.net/1871.1/fa487b49-4ea0-4ccb-b71b-2e729152e6e6

Economic evaluation in stratified medicine: methodological issues and challenges

Autor: W. Ken Redekop, Maarten J. Postma, Mark J. C. Nuijten, Hans-Joerg Fugel

Publikováno v: Frontiers in Pharmacology, Vol 7 (2016)
Frontiers in Pharmacology, 7:113. Frontiers Media S.A.
Frontiers in Pharmacology
Frontiers in Pharmacology, 7(113):113. Frontiers Media SA

Background: Stratified Medicine (SM) is becoming a practical reality with the targeting of medicines by using a biomarker or genetic-based diagnostic to identify the eligible patient sub-population. Like any healthcare intervention, SM interventions

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4347b3941842980623e257125836eb89
https://pure.eur.nl/en/publications/e7810cac-65f3-4630-b880-2376ecc20694